| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/31/2002 | EP1226115A1 Novel carbamates and ureas |
| 07/31/2002 | EP1226112A2 Retro-anandamides, high affinity and stability cannabinoid receptor ligands |
| 07/31/2002 | EP1225956A1 Method and compositions for administering taxanes orally to human patients |
| 07/31/2002 | EP1225922A1 Selective toxin expression in angiogenic endothelial cells |
| 07/31/2002 | EP1225919A1 Treatment of cancer |
| 07/31/2002 | EP1225918A2 Conjugates useful in the treatment of prostate cancer |
| 07/31/2002 | EP1225917A2 Manufacture of polyglutamate-therapeutic agent conjugates |
| 07/31/2002 | EP1225911A1 Methods of treating or preventing cell, tissue, and organ damage using human myeloid progenitor inhibitory factor-1 (mpif-1) |
| 07/31/2002 | EP1225909A2 Fibroblast growth factor-5 (fgf-5) is a tumor associated t-cell antigen |
| 07/31/2002 | EP1225900A1 Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders |
| 07/31/2002 | EP1225896A1 Isoxazole derivatives to be used as phosphodiesterase vii inhibitors |
| 07/31/2002 | EP1225894A1 Fab i inhibitors |
| 07/31/2002 | EP1225884A1 Method for administering a phosphodiesterase 4 inhibitor |
| 07/31/2002 | EP1225872A1 New and improved formulation for paclitaxel |
| 07/31/2002 | EP1225871A2 Method for the formulation of substances having a low water-solubility and lipophilicity and formulation thus obtained |
| 07/31/2002 | EP0920630B1 Prion binding proteins and uses thereof |
| 07/31/2002 | EP0825873B1 Anticancer vaccine comprising il6/il6 receptor transfected cells |
| 07/31/2002 | EP0825848B1 Translucent collagen formulations |
| 07/31/2002 | EP0824534B1 9,10 disubstituted camptothecin derivatives with antitumor activity |
| 07/31/2002 | EP0764152B1 Substituted indolylmethylene-oxindole analogues as tyrosine kinase inhibitors |
| 07/31/2002 | EP0719267B1 Second messenger cell signaling inhibitors |
| 07/31/2002 | EP0708656B1 Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines |
| 07/31/2002 | CN1361792A Cyclic peptide derivatives as inhibitors of integrin alpha/beta |
| 07/31/2002 | CN1361783A Thiazoloderivatives and pharmaceutical compositions containing them |
| 07/31/2002 | CN1361782A Substituted imidazothiazoles as antidepressant agents |
| 07/31/2002 | CN1361780A Purine derivatives, preparation method and pharmaceutical compositions containing same |
| 07/31/2002 | CN1361779A New compounds |
| 07/31/2002 | CN1361773A Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods |
| 07/31/2002 | CN1361767A 1,4,5,6-tetrahydropyrimidine derivative as a vitronectin inhibitor |
| 07/31/2002 | CN1361760A Novel interleukin-1 and tumor necrosis factor-alpha modulators, syntheses of said modulators and methods of using said modulators |
| 07/31/2002 | CN1361700A Treatment of refractory human tumors with epidermal growth factor receptor antagonists |
| 07/31/2002 | CN1361697A Use of ginkgo extract |
| 07/31/2002 | CN1361693A Use of 1,4-benzothiazepine derivatives as drugs overcoming carcinostatic tolerance |
| 07/31/2002 | CN1361690A Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents |
| 07/31/2002 | CN1361685A Sustained release compositions, process for producing the same and use thereof |
| 07/31/2002 | CN1361682A A liposome composition having resistance to freeze/thaw damage |
| 07/31/2002 | CN1361677A Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same |
| 07/31/2002 | CN1361286A Construction and application of recombinant probiotics strain to express human endothelial cell inhibin |
| 07/31/2002 | CN1361180A New polypeptide corticotrophin releasing factor 8.8 and polynucleotides encoding this polypeptide |
| 07/31/2002 | CN1361106A Corter pseudolaricis acetic acid derivative and its medicinal composite and their antineoplastic and antifungal application |
| 07/31/2002 | CN1360913A Nanometer Xiaojing medicine and its prepn |
| 07/31/2002 | CN1360909A Nanometer cinobufagin medicine and its prepn |
| 07/31/2002 | CN1360907A Anticancer Chinese herbal medicine and its prepn |
| 07/31/2002 | CN1360905A Cancer treating astringent medicine decoction |
| 07/31/2002 | CN1360894A Epimedium polysaccharide and its application in preparing medicine for raising body's immunity |
| 07/31/2002 | CN1360891A Dithiolane amylene hepyrroleketone and its relative monoxide and dioxide using as antitumour agent |
| 07/31/2002 | CN1088374C Food ingredients of beneficial for coronary heart diseases and tumor patients |
| 07/31/2002 | CA2369462A1 Nicotinamide acids, amides, and their mimetics active as inhibitors of pde4 isozymes |
| 07/30/2002 | US6426417 Processes and intermediates useful to make antifolates |
| 07/30/2002 | US6426413 Inhibitors of caspases |
| 07/30/2002 | US6426401 Pharmaceutical composition containing an inhibitor of immunoglobulin-receptor interaction |
| 07/30/2002 | US6426367 Methods for selectively occluding blood supplies to neoplasias |
| 07/30/2002 | US6426357 Antagonists of follicle stimulating hormone activity |
| 07/30/2002 | US6426353 α v integrin receptor antagonists |
| 07/30/2002 | US6426351 Administering in combination with chemotherapeutic agents that directly damage dna; extremely cytotoxic |
| 07/30/2002 | US6426349 Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes for neoplasia |
| 07/30/2002 | US6426345 Phosphodiesterase inhibitors; antiinflammatory agents |
| 07/30/2002 | US6426340 Complex with glycine or taurine |
| 07/30/2002 | US6426334 Administering nucleotide sequence |
| 07/30/2002 | US6426217 MAGE-3 peptides presented by HLA class II molecules |
| 07/30/2002 | US6426094 Method of enhancing the efficacy of anti-tumor agents |
| 07/30/2002 | US6426075 Genetic engineered polypeptide; killing cancer cells |
| 07/30/2002 | US6426067 Cardiovascular disorders; antitumor agents |
| 07/30/2002 | CA2268433C Improved interferon polymer conjugates |
| 07/30/2002 | CA2236021C Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities: process of making metho ds of using and compositions thereof |
| 07/30/2002 | CA2228997C Benzothiophene compounds |
| 07/30/2002 | CA2119351C Phosphoramidate analogs of 5-fluoro-2'-deoxyuridine |
| 07/30/2002 | CA2104461C Therapeutic compositions to protect and resuscitate mammalian cells and methods for preparing and using same |
| 07/30/2002 | CA2075291C Anti-tumor agent derived from dextrane |
| 07/30/2002 | CA2039230C Monoclonal antibodies that inhibit growth of kaposi's sarcoma |
| 07/26/2002 | CA2369264A1 Method of treating certain cancers using an estrogen agonist/antagonist |
| 07/25/2002 | WO2002057778A1 Screening assay for cotranslational translocation interfering compounds |
| 07/25/2002 | WO2002057741A2 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (sclc) |
| 07/25/2002 | WO2002057492A1 Methods and compositions for detecting polynucleotide duplex damage |
| 07/25/2002 | WO2002057489A2 Method of determining a chemotherapeutic regimen based on ercc1 and ts expression |
| 07/25/2002 | WO2002057483A2 Method of identifying modulators of nogo-functions |
| 07/25/2002 | WO2002057473A1 Method for inhibiting vegf and epo gene expression by quercetin |
| 07/25/2002 | WO2002057460A2 Polynucleotides encoding human phosphatases |
| 07/25/2002 | WO2002057454A2 Receptors and membrane-associated proteins |
| 07/25/2002 | WO2002057453A2 Polypetides and nucleic acids encoding same |
| 07/25/2002 | WO2002057452A2 Human proteins, polynucleotides encoding them and methods of using the same |
| 07/25/2002 | WO2002057450A2 Proteins and nucleic acids encoding same |
| 07/25/2002 | WO2002057449A1 Novel gene tifa |
| 07/25/2002 | WO2002057444A1 Human apoptosis-associated genes and human apoptosis-associated proteins produced thereby |
| 07/25/2002 | WO2002057427A2 Mammalian tumor susceptibility gene products and their uses |
| 07/25/2002 | WO2002057413A2 Peptides for activation and inhibition of delta pkc |
| 07/25/2002 | WO2002057409A2 Antisense modulation of src-2 expression |
| 07/25/2002 | WO2002057327A1 Method of preparing poly(vinyl pivalate) |
| 07/25/2002 | WO2002057316A1 Novel monoclonal antibody |
| 07/25/2002 | WO2002057309A1 Novel g protein-coupled receptor protein and dna thereof |
| 07/25/2002 | WO2002057306A1 Antibodies to non-functional p2x7 receptor diagnosis and treatment of cancers and other conditions |
| 07/25/2002 | WO2002057299A2 Vegfr-3 binding peptides and their use for inhibiting angiogenesis |
| 07/25/2002 | WO2002057290A2 Novel fibronectin epitopes and proteinaceous molecules capable of binding said epitopes |
| 07/25/2002 | WO2002057285A1 Fullerene derivative and composition comprising the same |
| 07/25/2002 | WO2002057284A1 New inhibitors against galectins |
| 07/25/2002 | WO2002057273A1 Serine protease inhibitors comprising a hydrogen-bond acceptor |
| 07/25/2002 | WO2002057271A2 Thienopyrimidine-based inhibitors of the src family |
| 07/25/2002 | WO2002057269A1 Synthesis of temozolomide and analogs |
| 07/25/2002 | WO2002057268A1 Synthesis of temozolomide and analogs |
| 07/25/2002 | WO2002057265A1 Compounds substituted with bicyclic amino groups |